what class of medication is tirzepatide FDA Approves Tirzepatide, A Potential Blockbuster Drug for Type 2 Diabetes Semaglutide vs Tirzepatide for Weight
Description
In early October, the FDA pulled Eli Lillys tirzepatide sold as Mounjaro for diabetes and Zepbound for obesity off its drug shortage list after nearly two years
Have cardiovascular concerns
The fixed 2mg dose was effective across body weight ranges in clinical trials
The earliest potential for generic competition is post-2037, contingent on patent expirations and the outcome of potential patent litigations
